搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
18 小时
AbbVie和Richter扩大中枢神经系统合作伙伴关系,达成新协议
伊利诺伊州北芝加哥 - 艾伯维公司(纽约证券交易所代码:ABBV)和Gedeon Richter Plc.宣布达成协议,共同发现和开发治疗神经精神疾病的新疗法。这项合作建立在近20年的合作伙伴关系基础之上,该合作关系已经产生了中枢神经系统疗法,包括cariprazine(VRAYLAR® / REAGILA®)和研究中的药物ABBV-932。
Pharmaceutical Technology
2 小时
AbbVie and Richter partner for neuropsychiatric treatments
AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new treatments for neuropsychiatric conditions.
14 小时
AbbVie, Gedeon Richter collaborate for discovery, development of novel targets
AbbVie (ABBV) and Gedeon Richter announced a new discovery, co-development and license agreement to advance novel targets for the potential ...
Zacks.com on MSN
1 天
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
1 天
AbbVie: Expect A Beat-And-Raise Q3 2024
AbbVie should report strong Q3 2024 results next week and increase the full-year guidance. Explore more details here.
PharmTech
13 小时
FDA Approves AbbVie Therapy for Adults with Advanced Parkinson’s Disease
Vyalev, also known as Produodopa, has been approved in 35 countries, with more than 4200 patients having started treatment.
1 天
AbbVie (ABBV) Gets a Buy from Piper Sandler
In a report released today, Christopher Raymond from Piper Sandler maintained a Buy rating on AbbVie (ABBV – Research Report), with a ...
6 天
on MSN
Analysts revise AbbVie stock price target ahead of earnings
Related: Analyst revises AbbVie stock price target on drug-sale estimates Sales eroded, however, as Humira faced competition ...
gulftoday
21 小时
CRISP Program, a new step by AbbVie to foster scientific expertise in the Middle East and ...
AbbVie, a global, research-driven biopharmaceutical company, organized a visit to its R&D facilities—the AbbVie Cambridge ...
24/7 Wall St
9 天
Dividend Aristocrat AbbVie Just Paid Investors; Here's How Much They Received
AbbVie Inc. (NYSE: ABBV) is rewarding its shareholders once again with a quarterly dividend of $1.55, payable on Tuesday Oct.
7 天
艾伯维公司表现\"非常出色\",但吉姆·克莱默最喜欢的是雅培
On CNBC's "Mad Money Lightning Round," Jim Cramer said AbbVie Inc. (NYSE:ABBV) is doing "very, very well." However, he added that Abbott Laboratories (NYSE:ABT) remains his favorite in the group right ...
7 天
on MSN
AbbVie wins FDA nod for infusion treatment for advanced Parkinson’s disease
Vyalev is the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for advanced Parkinson’s disease.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈